OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
-0.00155
-8.59%
0.0137 / 0.02 (45000 x 48000)
36 Toronto Street
Suite 701
Toronto, ON M5C 2C5
Canada
36 Toronto Street
Suite 701
Toronto, ONT M5C 2C5
Canada
Prof. Nutt is a psychiatrist and the Edmund J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept of Medicine, Imperial College London where he uses a range of brain imaging techniques to explore the causes of addiction and other psychiatric disorders and to search for new treatments. Prof. Nutt has published over 400 original research papers, a similar number of reviews and books chapters, eight government reports on drugs and 28 books, including one for the general public entitled "Drugs: Without The Hot Air", that won the Transmission Prize in 2014. Prof. Nutt is currently the President of the European Brain Council and Founding Chair of Drug Science. Previously he held the position of President of the British Association of Psychopharmacology, the British Neuroscience Association, and the European College of Neuropsychopharmacology. He broadcasts widely to the general public both on radio and television. In 2010, The Times Eureka science magazine voted him one of the 100 most important figures in British Science, and the only psychiatrist on the list. In 2013, Mr. Nutt was awarded the John Maddox Prize from Nature/Sense about Science for standing up for science.
None
Suite 527 - 2560 Matheson BLVD E,
Mississauga, ON L4Y 4Y9
Canada
250 2 St SW #1000
Calgary, AB T2P 0C1
Canada
The Company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief, relaxation and assist with restful sleeping.
The company does not own or lease any property. All of its operations (including pre-clinical trials and product development) accrue in facilities that are owned or leased by the companies that are providing services to the company.